600267 海正药业
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额832,0342,031,6762,184,0941,456,6372,152,141
投资活动产生之现金流量净额(285,480)(369,101)(290,361)(292,674)(665,185)
筹资活动产生之现金流量净额(753,158)(1,633,388)(2,036,945)(1,004,207)(1,505,405)
汇率变动对现金及现金等价物的影响(3,847)(887)3,4744,7186,526
现金及现金等价物净增加/(减少)(210,450)28,301(139,738)164,474(11,922)
期初现金及现金等价物余额1,218,1851,189,8841,329,6231,165,1491,177,071
期末现金及现金等价物余额1,007,7351,218,1851,189,8841,329,6231,165,149